CVS Health Launches Company To Produce Cheaper ‘Biosimilar’ Versions Of Expensive Biotech Drugs
CVS Health is launching Cordavis, a subsidiary that will collaborate with manufacturers to produce and commercialize more affordable biosimilar drugs derived from biotechnology.